Kaviva
Healthcare Software · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4495 Roosevelt Blvd Ste 338, Jacksonvill...Phone Number
(800) 648-7779Website
www.kaviva.comRevenue
<$5 MillionIndustry
About Kaviva
Kaviva Org Chart
Is Kaviva your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Kaviva is spiking on competitors!
Kaviva, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Kaviva launches new products
Earning: See what the market has to say on Kaviva recently announced quarterly report
Click to see if Kaviva had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Kaviva has new funding data
Check if Kaviva has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Kaviva
Recommended Actions
Reach out to Masked Content who joined Kaviva as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Kaviva is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Kaviva is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Kaviva.
Kaviva Tech Stack
A closer look at the technologies used by Kaviva
Kaviva News & Media
Sensei Biotherapeutics Announces Inclusion in Russell 2000 Index
BOSTON and ROCKVILLE, Md., March 22, 2021 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical-stage immunotherapy company focused on the discovery and development of next generation therapeutics for cancer, today announced that it will be added to the Russell 2000® Index effective March 22, 2021, as part of its quarterly initial public offering (IPO) additions. The Russell 2000® Index measures the performance of the small cap segment of the U.S. equity market. MembershipSensei Biotherapeutics Announces Closing of Initial Public Offering
BOSTON and ROCKVILLE, Md., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc., a clinical-stage immunotherapy company focused on the...Sensei Biotherapeutics Announces Closing of Initial Public Offering
BOSTON and ROCKVILLE, Md., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc., a clinical-stage immunotherapy company focused on the discovery and development of next generation therapeutics for cancer, today announced the closing of its initial public offering of 7,000,052 shares of its common stock on February 8, 2021, as well as the issuance of an additional 1,030,243 shares pursuant to the exercise by the underwriters of their option to purchase additional shares on FebruaryRockville immunotherapy company Sensei Biotherapeutics executes $133M IPO
Maryland biotech Sensei Biotherapeutics has officially moved to the public arena — with $133M in proceeds from its IPO. It's the latest in a string of public offerings in the local life sciences space.
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Kaviva
Multichannel communications delivered at scale. Easily find and deliver the right message, to the right person, at the right time. Kaviva is a multichannel communications and health technology platform provider, delivering HIPAA-secure solutions to organizations seeking to transform health, outcomes & engagement. Kaviva's tools allow customers to e... Read More